FTC Signs Off On Grifols-Talecris Deal Divestitures
By Pete Brush ( June 1, 2011, 1:32 PM EDT) -- The Federal Trade Commission signed off Wednesday on Grifols SA's antitrust-related divestitures of two plasma collection centers and a blood fractionation facility as part of its $3.4 billion purchase of rival medical researcher Talecris Biotherapeutics Holdings Corp....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.